Breast Cancer
Showing NaN - NaN of 241
Biomarkers in Subjects With Untreated Solid Tumors
Completed
- Breast Cancer
- +12 more
- Blood Sample Collection
-
Phoenix, Arizona
- +118 more
Aug 31, 2022
Malignant Tumor of Breast, Breast Cancer Trial in United States (Genomically Directed Monotherapy, Observation/Standard Therapy)
Active, not recruiting
- Malignant Neoplasm of Breast
- Breast Cancer
- Genomically Directed Monotherapy
- Observation/Standard Therapy
-
Birmingham, Alabama
- +28 more
Aug 30, 2022
Breast Cancer, Cancer Trial in Worldwide (Nivolumab, Anastrozole, Palbociclib)
Completed
- Breast Cancer
- Cancer
- Nivolumab
- +2 more
-
Whittier, California
- +35 more
Jul 14, 2022
Breast Cancer Trial in Worldwide (biological, drug, other, procedure)
Active, not recruiting
- Breast Cancer
- nivolumab
- +6 more
-
Mobile, Alabama
- +255 more
Jul 21, 2022
Breast Cancer Trial in Worldwide (Elacestrant, Standard of Care)
Active, not recruiting
- Breast Cancer
- Elacestrant
- Standard of Care
-
Tucson, Arizona
- +167 more
Jul 19, 2022
Ovarian Cancer, Breast Cancer, Folic Acid Deficiency Trial in Chicago (Folic Acid Tablet)
Active, not recruiting
- Ovarian Cancer
- +2 more
- Folic Acid Tablet
-
Chicago, IllinoisRush University Medical Center
Jul 17, 2022
Breast Cancer Trial in Worldwide (Ribociclib, Letrozole, Goserelin)
Advanced or Metastatic Solid Tumors, Ovarian Cancer, NSCLC Trial in United States (NC762)
Recruiting
- Advanced or Metastatic Solid Tumors
- +3 more
-
New Haven, Connecticut
- +6 more
Jun 22, 2022
Breast Cancer Trial in United States (therapeutic conventional surgery, whole breast irradiation)
Active, not recruiting
- Breast Cancer
- therapeutic conventional surgery
- whole breast irradiation
-
Hot Springs, Arkansas
- +349 more
Jun 16, 2022
Quality of Life in Female Breast Cancer Survivors and Their
Completed
- Breast Cancer
- +5 more
- cognitive assessment
- +2 more
-
Monterey, California
- +103 more
Jun 8, 2022
Breast Cancer Trial in United States (Lapatinib, Letrozole, Trastuzumab)
Breast Cancer, Triple Negative Breast Cancer, Residual Cancer Trial in United States (Atezolizumab, Sacituzumab govitecan)
Recruiting
- Breast Cancer
- +3 more
- Atezolizumab
- Sacituzumab govitecan
-
San Francisco, California
- +8 more
May 25, 2022
Breast Cancer Trial in Worldwide (Enzalutamide, exemestane, Placebo (for enzalutamide))
Breast Cancer Trial in Worldwide (Amcenestrant-matching , SAR439859, Palbociclib)
Active, not recruiting
- Breast Cancer
- Amcenestrant-matching placebo
- +5 more
-
Daphne, Alabama
- +299 more
May 5, 2022
Breast Cancer Trial in Chicago, Wauwatosa (Taking Charge during Treatment (TCT) Intervention)
Recruiting
- Breast Cancer
- Taking Charge during Treatment (TCT) Intervention
-
Chicago, Illinois
- +1 more
Apr 11, 2022
Diabetes, Breast Cancer Trial in Chicago, New Hyde Park, New York (Integrated Intervention for Breast Cancer Survivors with
Recruiting
- Diabetes
- Breast Cancer
- Integrated Intervention for Breast Cancer Survivors with Diabetes
- Attention Control
-
Chicago, Illinois
- +2 more
Apr 13, 2022
Breast Cancer Trial in Worldwide (Palbociclib, Standard Adjuvant Endocrine Therapy)
Active, not recruiting
- Breast Cancer
- Palbociclib
- Standard Adjuvant Endocrine Therapy
-
Mobile, Alabama
- +437 more
Mar 21, 2022
Breast Cancer, Renal Cell Carcinoma Trial in United States (IPI-549 (eganelisib), Atezolizumab, nab-paclitaxel)
Active, not recruiting
- Breast Cancer
- Renal Cell Carcinoma
- IPI-549 (eganelisib)
- +3 more
-
Chandler, Arizona
- +23 more
Apr 1, 2022
Breast Cancer Trial in United States (Tucatinib in Combination with Palbociclib and Letrozole)
Active, not recruiting
- Breast Cancer
- Tucatinib in Combination with Palbociclib and Letrozole
-
Tucson, Arizona
- +5 more
Mar 8, 2022